View |
|
DRP-4870-04
|
Betamethasone + Dexchlorpheniramine Maleate
|
None
|
250 mcg/2 mg
|
Tablet
|
Corticosteroid/Antihistamine
|
Interphil Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
08 September 2023
|
07 November 2028
|
View |
|
DRP-4879-05
|
Atorvastatin (as calcium)
|
Linmervast-20
|
20 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
13 September 2023
|
07 November 2028
|
View |
|
DRP-4961-23
|
Cefixime (as trihydrate)
|
Maedix TF
|
100 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Sakar Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 October 2023
|
27 November 2028
|
View |
|
DRP-5137-06
|
Atorvastatin (as calcium)
|
Koditorz
|
40 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitors
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
11 October 2023
|
13 February 2029
|
View |
|
DRP-5185-07
|
CETIRIZINE (as Dihydrochloride )
|
Lergic
|
10 mg
|
Tablet
|
Antihistamine
|
LifeSquare Laboratories, Inc.
|
Philippines
|
Renewal
|
12 March 2024
|
03 March 2029
|
View |
|
DRP-5185-08
|
CETIRIZINE (as dihydrochloride)
|
LERIF
|
10 mg
|
Tablet
|
ANTIHISTAMINE
|
LifeSquare Laboratories, Inc.
|
Philippines
|
Renewal
|
26 March 2024
|
03 March 2029
|
View |
|
DRP-5240-25
|
Ceftriaxone (as sodium)
|
Ceftriacirc
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Scott-Edil Advance Research Laboratories & Education Ltd
|
India
|
Renewal
|
21 May 2024
|
07 April 2029
|
View |
|
DRP-5610
|
Cefpodoxime (as proxetil)
|
Ceforan-200
|
200 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Drug International Limited
|
Philippines
|
Automatic Renewal
|
05 September 2023
|
14 August 2028
|
View |
|
DRP-5769-10
|
Gliclazide
|
None
|
30 mg
|
Modified-Release Tablet
|
Oral Hypoglycemic Agent
|
Bal Pharma Limited
|
India
|
Renewal
|
12 June 2024
|
13 June 2029
|
View |
|
DRP-5909-07
|
Pantoprazole (as sodium sesquihydrate)
|
None
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 October 2023
|
12 January 2025
|
View |
|
DRP-5926-06
|
Cefixime (as Trihydrate)
|
Bendexime
|
100 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
05 October 2023
|
12 October 2026
|
View |
|
DRP-5930-11
|
Omeprazole Sodium
|
Omee
|
40 mg
|
Lyophilized Powder for Injection
|
Proton Pump Inhibitor
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
10 October 2023
|
05 December 2028
|
View |
|
DRP-6008-01
|
Cefuroxime (as sodium)
|
Superoxime
|
750 mg
|
Lyophilized Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
Renewal
|
14 September 2023
|
25 January 2029
|
View |
|
DRP-6213-01
|
Albendazole
|
Senzol
|
400 mg
|
Chewable Tablet
|
Anthelmintic (Benzimidazole derivative)
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
06 October 2023
|
07 July 2025
|
View |
|
DRP-6422-16
|
Omeprazole (as Sodium)
|
Jumep
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Drug International Ltd.
|
Bangladesh
|
CLIDP Conversion
|
10 October 2023
|
17 June 2025
|
View |
|
DRP-6449-11
|
Metronidazole
|
Nicozole
|
500 mg/100 mL (0.5% w/v)
|
Solution for IV Infusion
|
Antiprotozoal
|
AXA Parenterals Ltd.
|
India
|
Renewal
|
16 April 2024
|
05 March 2030
|
View |
|
DRP-6558-05
|
Dibencozide
|
Ziben
|
3 mg
|
Capsule
|
Vitamin
|
LifeSquare Laboratories, Inc.
|
Philippines
|
Renewal
|
22 February 2024
|
03 March 2029
|
View |
|
DRP-6558-06
|
DIBENCOZIDE
|
Dibex
|
3mg
|
Capsule
|
VITAMINS
|
LifeSquare Laboratories, Inc
|
Philippines
|
Renewal
|
14 February 2024
|
03 March 2029
|
View |
|
DRP-6559-04
|
DIBENCOZIDE
|
Dibex
|
1 mg
|
Capsule
|
VITAMINS
|
Lifesquare Laboratories Inc.
|
Philippines
|
Renewal
|
01 March 2024
|
03 March 2029
|
View |
|
DRP-6559-05
|
Dibencozide
|
Ziben
|
1 mg
|
Capsule
|
Vitamin
|
LifeSquare Laboratories, Inc.
|
Philippines
|
Renewal
|
21 February 2024
|
03 March 2029
|